EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lonza Group's enterprise value is CHF39,167 Mil.
Lonza Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF883 Mil. Therefore, Lonza Group's EV-to-EBITDA for today is 44.36.
The historical rank and industry rank for Lonza Group's EV-to-EBITDA or its related term are showing as below:
XSWX:LONN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.17 Med: 19.34 Max: 44.65
Current: 44.36
During the past 13 years, the highest EV-to-EBITDA of Lonza Group was 44.65. The lowest was 9.17. And the median was 19.34.
XSWX:LONN's EV-to-EBITDA is ranked worse than 89.74% of 117
companies
in the Medical Diagnostics & Research industry
Industry Median: 15.81
vs XSWX:LONN: 44.36
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Lonza Group's stock price is CHF522.80.
Lonza Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF8.880. Therefore, Lonza Group's PE Ratio for today is 58.87.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Lonza Group EV-to-EBITDA Historical Data
The historical data trend for Lonza Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lonza Group's EV-to-EBITDA
For the Diagnostics & Research subindustry, Lonza Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lonza Group's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Lonza Group's EV-to-EBITDA falls into.
Lonza Group EV-to-EBITDA Calculation
Lonza Group's EV-to-EBITDA for today is calculated as:
Lonza Group's current Enterprise Value is CHF39,167 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF883 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lonza Group (XSWX:LONN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Lonza Group's PE Ratio for today is calculated as:
Lonza Group's share price for today is CHF522.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF8.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Lonza Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:LONN has been successfully added to your 